Very severe thrombocytopenia and fragmentation hemolysis mimicking thrombotic thrombocytopenic purpura associated with a giant intracardiac vegetation infected with Staphylococcus epidermidis: Role of monocyte procoagulant activity induced by bacterial supernatant

American Journal of Hematology

Volumn 82, Issue 8, 2007, Pages 766-771

  Selleng, Kathleen ^a   Warkentin, Theodore E ^b,c   Greinacher, Andreas ^a   Morris, Andrew M ^b   Walker, Irwin R ^b   Heggtveit, H Alexander ^b   Eichler, Petra ^a   Cybulsky, Irene J ^b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b MCMASTER UNIVERSITY   (Canada)

^c HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BLOOD CLOTTING FACTOR 10A; CORTICOSTEROID; FUROSEMIDE; HEPARIN; IMMUNOGLOBULIN; LEVOFLOXACIN; LIPOPOLYSACCHARIDE; PREDNISONE; RIFAMPICIN; THROMBIN ANTITHROMBIN COMPLEX; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIUM CULTURE; CASE REPORT; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; HEMOLYSIS; HEPARINIZATION; HUMAN; IMMUNOTHERAPY; MALE; MONOCYTE; PLASMAPHERESIS; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; SUPERNATANT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT FAILURE;

BLOOD COAGULATION; CELLS, CULTURED; FACTOR XA; HEMOLYSIS; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; PLATELET COUNT; PURPURA, THROMBOTIC THROMBOCYTOPENIC; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; THROMBOCYTOPENIA;

EID: 34547655733     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20821     Document Type: Article

References (30)

1. Bouza E, Menasalvas A, Munoz P, Vasallo FJ, Moreno MDM, Fernandez MAG. Infective endocarditis - A prospective study at the end of the twentieth century: New predisposing conditions, new etiologic agents, and still a high mortality. Medicine (Baltimore) 2001;80:298-307.
2. Olaison L, Hogevik H, Alestig K. Fever, C-reactive protein, and other acute-phase reactants during treatment of infective endocarditis. Arch Intern Med 1997;157:885-892.
3. Arnold DM, Smaill F, Warkentin TE, Christjanson, Walker I. Cardiobacterium hominis endocarditis associated with very severe thrombocytopenia and platelet autoantibodies. Am J Hematol 2004;76:373-377.
4. Bayer AS, Theofilopoulos AN, Eisenberg R, Friedman SG, Guze LB. Thrombotic thrombocytopenic purpura-like syndrome associated with infective endocarditis. A possible immune complex disorder. JAMA 1977;238:408-410.
5. Moore MR, Poon MC. Syndrome resembling thrombotic thrombocytopenic purpura associated with bacterial endocarditis. South Med J 1980:73:541-542.
6. Silva HL, Strabelli TM, Cunha ER, Neres SF, Camargo LF Uip DE. Nosocomial coagulase negative Staphylococci bacteremia: Five year prospective data collection. Braz J Infect Dis 2000;4:271-274.
7. Zinkernagel AS, Speck RF, Ruef C, Zingg W, Berger-Bachi B, Springer B. Rapidly destructive Staphylococcus epidermidis endocarditis. Infection 2005;33:148-150.
8. Moura L, Zamorano J, Moreno R, et al. Perioperative mortality and long-term outcome of infective endocarditis. Rev Port Cardiol 2002;21:989-999.
9. Noel GJ, O'Loughlin JE, Edelson PJ. Neonatal Staphylococcus epidermidis right-sided endocarditis: Description of five catheterized infants. Pediatrics 1988;82:234-239.
10. Von Eiff C, Proctor RA, Peters G. Coagulase-negative staphylococci. Pathogens have major role in nosocomial infections. Postgrad Med 2001;110:63-70, 73.
11. Levine MN, Hirsh J, Gent M, et al. A randomized trial comparing activated partial thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. Arch Intern Med 1994;154:49-56.
12. Pouplard, Reverdiau-Moalic P, Piquemal R, et al. A simplified and low-cost one-stage chromogenic assay for tissue factor dependent procoagulant activity of endothelial cells. Thromb Res 1995;80:527-534.
13. Pouplard C, Iochmann S, Renard B, et al. Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia. Blood 2001;97:3300-3302.
14. Visentin GP, Wolfmeyer K, Newman PJ, Aster RH. Detection of drug-dependent, platelet-reactive antibodies by antigen-capture ELISA and flow cytometry. Transfusion 1990;30:694-700.
15. Rallidis LS, Komninos KA, Papasteriadis EG. Pacemaker-related endocarditis: The value of transoesophageal echocardiography in diagnosis and treatment. Acta Cardiol 2003;58:31-34.
16. Marraffa J, Guharoy R, Duggan D, Rose F, Nazeer S. Vancomycin-induced thrombocytopenia: A case proven with rechallenge. Pharmacotherapy 2003;23:1195-1198.
17. Mizon P, Kiefel V, Mannessier L, Mueller-Eckhardt C, Goudemand J. Thrombocytopenia induced by vancomycin-dependent platelet antibody. Vox Sang 1997;73:49-51.
18. Grossjohann B, Eichler P, Greinacher A, Santoso S, Kroll H. Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: Characterization of targets on platelets and red blood cells. Transfusion 2004;44:1033-1040.
19. Aster RH. Drug-induced immune cytopenias. Toxicology 2005;209:149-153.
20. Thomas M, Heyll A, Meckenstock G, Vogt M, Aul C. Embolisierende Aortenklappenendokarditis als Differentialdiagnose der thrombotisch- thrombozytopenischen Purpura [Embolizing aortic valve endocarditis in the differential diagnosis of thrombotic thrombocytopenic purpura]. Dtsch Med Wochenschr 1992;117:738-742.
21. Murrin RJ, Murray JA. Thrombotic thrombocytopenic purpura: Aetiology, pathophysiology and treatment. Blood Rev 2006;20:51-60.
22. Selleng K, Engelmann S, Thiel M, et al. Blood cell activation patterns induced by soluble S. aureus products. Hamostaseologie 2006;1:A52 [abstract].
23. van Langevelde P, van Dissel JT, Ravensbergen E, Appelmelk BJ, Schrijver IA, Groeneveld PH. Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: Quantitative measurements and biological reactivities. Antimicrob Agents Chemother 1998;42:3073-3078.
24. Bancsi MJLMF, Veltrop MHAM, Bertina RM, Thompson J. Role of monocytes and bacteria in Staphylococcus epidermidis endocarditis. Infect Immun 1998;66:448-450.
25. Veltrop MH, Bancsi MJ, Bertina RM, Thompson J. Role of monocytes in experimental Staphylococcus aureus endocarditis. Infect Immun 2000;68:4818-4821.
26. Bancsi MJLMF, Veltrop MHAM, Bertina RM, Thompson J. Influence of monocytes and antibiotic treatment on tissue factor activity of endocardial vegetations in rabbits infected with Streptococcus sanguis. Infect Immun 1996;64:448-451.
27. Buiting AG, Thompson J, van der KD, Schmal-Bauer WC, Bertina RM. Procoagulant activity of endocardial vegetations and blood monocytes in rabbits with Streptococcus sanguis endocarditis. Thromb Haemost 1989;62:1029-1033.
28. Mattsson E, Herwald H, Egesten A. Superantigens from Staphylococcus aureus induce procoagulant activity and monocyte tissue factor expression in whole blood and mononuclear cells via IL-1β. J Thromb Haemost 2003;1:2569-2576.
29. Mattsson E, Herwald H, Björck L, Egesten A. Peptidoglycan from Staphylococcus aureus induces tissue factor expression and procoagulant activity in human monocytes. Infect Immun 2002;70:3033-3039.
30. Mattsson E, Hartung T, Morath S, Egesten A. Highly purified lipoteichoic acid from Staphylococcus aureus induced procoagulant activity and tissue factor expression in human monocytes but is a weak inducer in whole blood: Comparison with peptidoglycan. Infect Immun 2004;72:4322-4326.